荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

荃信生物-B(02509)

28.150-1.050-3.60%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
荃信生物-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.qyuns.net
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。
- 04-26
  年度报告
  2023年度报告
  2023年度报告
- 03-28
  年度报告
  截至二零二三年十二月三十一日止年度之财务业绩
  截至二零二三年十二月三十一日止年度之财务业绩
- 03-12
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

最高

30.550

今开

29.550

量比

1.19

最低

27.500

昨收

29.200

换手率

0.07%

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"02509","data":{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":28.15,"timestamp":1715846889030,"preClose":29.2,"halted":0,"volume":143000,"delay":0,"floatShares":204749200,"shares":222071600,"eps":-2.6695323,"marketStatus":"已收盘","marketStatusCode":5,"change":-1.05,"latestTime":"05-16 16:08:09","open":29.55,"high":30.55,"low":27.5,"amount":4104100,"amplitude":0.104452,"askPrice":28.2,"askSize":400,"bidPrice":28.15,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-2.66953229312,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715909400000},"adr":0,"listingDate":1710864000000,"adjPreClose":29.2,"openAndCloseTimeList":[[1715823000000,1715832000000],[1715835600000,1715846400000]],"volumeRatio":1.185345,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"18018648","market":"hk","media":"港交所","original_id":"N.HK6KGQNoHBDr","pdf_url":"https://static.tigerbbs.com/22c0fce819c54788b3f74f89f7386f28","pub_time":1714129260000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023年度报告","symbol":"02509","title":"2023年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0426/2024042603282_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":1,"hasEarnInfos":false,"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-26 19:01","pubTimestamp":1714129260,"gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17768425","market":"hk","media":"港交所","original_id":"N.HKGUFU7wATcq","pdf_url":"https://static.tigerbbs.com/1f7585eff5a4448c8880264848c1bcae","pub_time":1711615260000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至二零二三年十二月三十一日止年度之财务业绩","symbol":"02509","title":"截至二零二三年十二月三十一日止年度之财务业绩","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0328/2024032800985_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":1,"hasEarnInfos":false,"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-03-28 16:41","pubTimestamp":1711615260,"gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17693737","market":"hk","media":"港交所","original_id":"N.HK9Ebi84wUZo","pdf_url":"https://static.tigerbbs.com/c3802d17f9484379be2e8b70216bc51c","pub_time":1710195180000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"02509","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0312/2024031200008_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":1,"hasEarnInfos":false,"type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2024-03-12 06:13","pubTimestamp":1710195180,"gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":0.1103},{"period":"1month","weight":0.2668},{"period":"3month","weight":0.4747},{"period":"ytd","weight":0.4747}],"compareEarnings":[{"period":"1week","weight":0.0322},{"period":"1month","weight":0.1407},{"period":"3month","weight":0.2012},{"period":"6month","weight":0.0696},{"period":"1year","weight":-0.0449},{"period":"ytd","weight":0.1189}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事生物制药的中国公司。该公司主要从事自身免疫及过敏性疾病生物疗法的生物科技研发。该公司业务主要涵盖四大疾病领域，包括皮肤、风湿、呼吸道及消化道疾病。该公司正在研发的项目有8个，目标适应症包括银屑病、特应性皮炎、类风湿性关节炎、炎症性肠病、哮喘等。该公司核心产品有QX002N和QX005N。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"aProfile":null}}}